For research use only. PeptaBase is for informational and laboratory research reference only. No medical claims are made and nothing on this site is intended to diagnose, treat, cure or prevent any disease.
PeptaBase
500+ PubMed CitationsNo Affiliate LinksPrivate & Secure
Comparison

GHK-Cu vs Melanotan I: Evidence-Based Comparison

Compare GHK-Cu and Melanotan I: dosing, mechanisms, safety profiles, and research evidence. Citation-backed comparison.

Overview

A comparison of GHK-Cu and Melanotan I as melanocortin system-related peptides in cosmetic and dermal research, including mechanisms and evidence context.

Compared compounds
GHK-CuMelanotan I

Overview

GHK-Cu and Melanotan I both appear in cosmetic and dermal research, but they address entirely different mechanisms. GHK-Cu is primarily studied for collagen signaling and skin repair, while Melanotan I is studied for melanogenesis and photoprotection. They are occasionally compared in dermatology research contexts but represent distinct intervention strategies.

Mechanism Comparison

GHK-Cu acts as a copper-chelating tripeptide that influences collagen synthesis, extracellular matrix remodeling, and antioxidant signaling. Melanotan I is a synthetic analog of alpha-MSH studied for its ability to stimulate melanogenesis through MC1R receptor activity, leading to increased melanin production and potential UV photoprotection. The mechanisms share a skin focus but diverge entirely at the receptor and pathway level.

Dosing and Protocol Comparison

GHK-Cu is widely studied in topical formulations where concentration and delivery system determine efficacy, while injectable research also exists. Melanotan I has been primarily studied via subcutaneous injection in both animal models and limited human trials for photoprotection and skin cancer risk reduction in fair-skinned populations. The two compounds are rarely used in the same protocol and represent separate research questions.

Evidence Comparison

GHK-Cu has a broad and long-standing literature base in wound healing, skin biology, and collagen research. Melanotan I has more limited but higher-quality clinical research specifically in photoprotection, including formal trials. Both compounds have legitimate research histories in different dermal applications, making direct comparison less meaningful than understanding each independently.

Frequently asked questions

Which is better, GHK-Cu or Melanotan I?

GHK-Cu and Melanotan I are researched for different contexts, so the better choice depends on study goals, mechanism priorities, and protocol design.

Can you stack GHK-Cu and Melanotan I?

Some researchers evaluate GHK-Cu and Melanotan I together, but combination design depends on evidence quality, safety considerations, and whether overlapping mechanisms are appropriate for the research question.

What's the difference between GHK-Cu and Melanotan I?

The main differences are mechanism, dosing cadence, evidence maturity, and safety profile emphasis in the published literature.

Study Summaries

GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration
Journal / Year
Biomed Res Int / 2018
View on PubMed
GHK-Cu may prevent oxidative stress in skin
Journal / Year
Cosmetics / 2015
View on PubMed
Afamelanotide for Erythropoietic Protoporphyria
Journal / Year
N Engl J Med / 2015
View on PubMed
Systemic afamelanotide in EPP patients increases pain-free light exposure
Journal / Year
Acta Derm Venereol / 2009
View on PubMed

Related Peptides

GHK-CuMelanotan I

Compare other peptides

BPC-157 vs GHK-Cu

Related tools

Research Glossary